These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 33761582)

  • 61. Key steps in our journey to a COVID-19 vaccine program.
    Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
    Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
    [No Abstract]   [Full Text] [Related]  

  • 62. [Enlightening from optimizing post-authorization safety monitoring system of SARS-CoV-2 vaccines in major economies worldwide].
    Wang SY; Pan XJ; Deng X; Fu J; Zhang HJ; Ding LL; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):1096-1104. PubMed ID: 37482744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RNA-Based COVID-19 vaccine candidates with clinical phase trials in progress.
    Rudvan Al LI; Sönmezer MÇ; Ünal S
    Turk J Med Sci; 2021 Dec; 51(SI-1):3246-3252. PubMed ID: 34365779
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccine Strategy During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2021 Nov; 36(6):316-322. PubMed ID: 34060925
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19.
    Mustajab T; Kwamboka MS; Choi DA; Kang DW; Kim J; Han KR; Han Y; Lee S; Song D; Chwae YJ
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tanzania's position on the COVID-19 pandemic.
    Mfinanga SG; Mnyambwa NP; Minja DT; Ntinginya NE; Ngadaya E; Makani J; Makubi AN
    Lancet; 2021 Apr; 397(10284):1542-1543. PubMed ID: 33864748
    [No Abstract]   [Full Text] [Related]  

  • 67. Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
    Dyer O
    BMJ; 2021 Apr; 373():n969. PubMed ID: 33849893
    [No Abstract]   [Full Text] [Related]  

  • 68. COVID-19 vaccine and the cold chain implications for global adoption.
    Das MK
    Indian J Public Health; 2021; 65(3):307-310. PubMed ID: 34558497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. COVID-19 in the elderly people and advances in vaccination approaches.
    Dhama K; Patel SK; Natesan S; Vora KS; Iqbal Yatoo M; Tiwari R; Saxena SK; Singh KP; Singh R; Malik YS
    Hum Vaccin Immunother; 2020 Dec; 16(12):2938-2943. PubMed ID: 33270497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic.
    Moore S; Hill EM; Dyson L; Tildesley MJ; Keeling MJ
    Nat Med; 2022 Nov; 28(11):2416-2423. PubMed ID: 36302894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The race to make a COVID-19 vaccine.
    Boseley S
    Lancet; 2021 Sep; 398(10303):832-833. PubMed ID: 34481566
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical development and approval of COVID-19 vaccines.
    Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
    Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong.
    Kwok KO; Li KK; Tang A; Tsoi MTF; Chan EYY; Tang JWT; Wong A; Wei WI; Wong SYS
    Emerg Infect Dis; 2021 Jul; 27(7):1802-1810. PubMed ID: 34152948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 vaccines: what do we know so far?
    Dhillon P; Altmann D; Male V
    FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409
    [TBL] [Abstract][Full Text] [Related]  

  • 75. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic.
    Chen P; Shi X; He W; Zhong G; Tang Y; Wang H; Zhang P
    Hum Vaccin Immunother; 2022 Dec; 18(1):2040330. PubMed ID: 35321627
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Global pandemic vaccine development, production and distribution challenges for the world population.
    Injac R
    Int J Risk Saf Med; 2022; 33(3):235-248. PubMed ID: 35311714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Status of COVID-19 Pandemic Before the Administration of Vaccine.
    Thomas S
    Methods Mol Biol; 2022; 2410():93-108. PubMed ID: 34914043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mucosal and transdermal vaccine delivery strategies against COVID-19.
    Kumar A; Kumar A
    Drug Deliv Transl Res; 2022 May; 12(5):968-972. PubMed ID: 33993417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India.
    Victor PJ; Mathews KP; Paul H; Mammen JJ; Murugesan M
    Mayo Clin Proc; 2021 Sep; 96(9):2493-2494. PubMed ID: 34366135
    [No Abstract]   [Full Text] [Related]  

  • 80. COVID-19: Vaccines and therapeutics.
    Ponnampalli S; Venkata Suryanarayana Birudukota N; Kamal A
    Bioorg Med Chem Lett; 2022 Nov; 75():128987. PubMed ID: 36113669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.